S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities

Leede Jones Gab Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Leede Jones Gab. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Leede Jones Gab.

MarketRank evaluates a company based on community opinion, dividend strength, institutional and insider ownership, earnings and valuation, and analysts forecasts.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyDateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
Theratechnologies Inc. stock logo
THTX
Theratechnologies
1/5/2023Upgraded byLeede Jones GabAnalyst D. LoeHold -> Speculative BuyLow
Theratechnologies Inc. stock logo
TH
Theratechnologies
1/5/2023Upgraded byLeede Jones GabAnalyst D. LoeHold -> Speculative BuyN/A
Medical Facilities Co. stock logo
DR
Medical Facilities
11/11/2022Downgraded byLeede Jones GabAnalyst D. LoeBuy -> HoldN/A
Oncolytics Biotech Inc. stock logo
ONC
Oncolytics Biotech
3/4/2022Reiterated byLeede Jones GabAnalyst D. LoeSpeculative BuyN/A
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
3/4/2022Reiterated byLeede Jones GabAnalyst D. LoeSpeculative BuyLow
Antibe Therapeutics Inc. stock logo
ATBPF
Antibe Therapeutics
10/15/2021Downgraded byLeede Jones GabAnalyst D. LoeSpeculative Buy -> HoldHigh
Antibe Therapeutics Inc. stock logo
ATE
Antibe Therapeutics
10/15/2021Downgraded byLeede Jones GabAnalyst D. LoeSpeculative Buy -> HoldN/A
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
8/24/2021Reiterated byLeede Jones GabAnalyst D. LoeSpeculative BuyHigh
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
6/2/2021Reiterated byLeede Jones GabAnalyst D. LoeBuyLow
Liminal BioSciences Inc. stock logo
LMNL
Liminal BioSciences
3/26/2021Reiterated byLeede Jones GabAnalyst D. LoeHoldLow
K-Bro Linen Inc. stock logo
KBL
K-Bro Linen
3/19/2021Reiterated byLeede Jones GabAnalyst D. LoeBuyN/A
IMV Inc. stock logo
IMV
IMV
3/18/2021Reiterated byLeede Jones GabAnalyst D. LoeSpeculative BuyN/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
3/22/2021Upgraded byLeede Jones GabAnalyst D. LoeSpeculative Buy -> BuyN/A
IMV Inc. stock logo
IMV
IMV
3/18/2021Reiterated byLeede Jones GabAnalyst D. LoeSpeculative BuyHigh
Medical Facilities Co. stock logo
DR
Medical Facilities
3/12/2021Reiterated byLeede Jones GabAnalyst D. LoeBuyN/A
Profound Medical Corp. stock logo
PRN
Profound Medical
3/4/2021Reiterated byLeede Jones GabAnalyst D. LoeBuyN/A
Profound Medical Corp. stock logo
PROF
Profound Medical
3/4/2021Reiterated byLeede Jones GabAnalyst D. LoeBuyMedium
Extendicare Inc. stock logo
EXE
Extendicare
3/1/2021Reiterated byLeede Jones GabAnalyst D. LoeBuyN/A
Theratechnologies Inc. stock logo
THTX
Theratechnologies
2/26/2021Downgraded byLeede Jones GabAnalyst D. LoeSpeculative Buy -> HoldLow
Theratechnologies Inc. stock logo
TH
Theratechnologies
2/26/2021Downgraded byLeede Jones GabAnalyst D. LoeSpeculative Buy -> HoldN/A
Oncolytics Biotech Inc. stock logo
ONC
Oncolytics Biotech
2/24/2021Reiterated byLeede Jones GabAnalyst D. LoeSpeculative BuyN/A
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
2/24/2021Reiterated byLeede Jones GabAnalyst D. LoeSpeculative BuyHigh

MarketBeat Community Rating for Leede Jones Gab

Community Ranking:  2.3 out of 5 (
2.3 of 5 stars)
Outperform Votes:  230 (Vote Outperform)
Underperform Votes:  262 (Vote Underperform)
Total Votes:  492
MarketBeat's community ratings are surveys of what our community members think about Leede Jones Gab and other research firms. Vote "Outperform" if you believe Leede Jones Gab's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Leede Jones Gab's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools